 |
인쇄하기
취소
|
Dong-A, Daewoong enjoy brisk sales in domestic antiulcerant market
Dong-A Pharmaceutical and Daewoong Pharm saw their sales of Stillen and Albis soar in the third quarter of this year, according to market data.
Dong-A garnered 62.1 billion won in the accumulated nine-month of sales this year, followed by Albis with 29.1 billion won; Jeil’s Lanston (24.5 billion won), Pacific Pharm’s Pantoloc (19.5 billion won), Ildong’s Curan (19.2 billion won), Otsuka Kore...
Dong-A garnered 62.1 billion won in the accumulated nine-month of sales this year, followed by Albis with 29.1 billion won; Jeil’s Lanston (24.5 billion won), Pacific Pharm’s Pantoloc (19.5 billion won), Ildong’s Curan (19.2 billion won), Otsuka Kore...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.